Blackstone: Buy The Business, Get The AI Upside

Blackstone’s Q2 showed robust momentum with 22% fee-related earnings growth and $68B of inflows, highlighting continued strength in its diversified fee engine. The firm cites AI-related infrastructure investments as a key tailwind and notes valuation around ~23x forward earnings with ample dry powder. Guidance implied by the article points to expected double-digit fee growth by 2027, supporting a bullish compounder outlook.

Analysis

The market is still underestimating how much BX’s earnings durability comes from mix, not macro beta. A larger share of permanent capital and infrastructure-style mandates should lower the variance of fee growth versus more cyclical peers, which matters because the multiple is now pricing it more like a quality compounder than a fee-taker. If AI infrastructure remains a durable capital-formation theme, BX can monetize both direct deployment and follow-on fundraising, while also pulling share from managers whose platforms are narrower or more exposed to exit markets.

The first-order trade is not the headline earnings beat; it is the compounding path from inflows into recurring fee revenue. That can re-rate the stock over 6-18 months if deployment stays brisk and realizations recover, but in the next 1-3 months the key catalyst is whether fundraising momentum persists into the next quarter without a deterioration in private-markets exit conditions. The main second-order risk is that “dry powder” becomes a drag if capital is committed into overpriced AI infrastructure assets and future returns compress, which would eventually pressure fee growth, performance fees, and investor appetite.

Consensus is probably most complacent about cyclicality hiding inside a quality story. If rates stay higher for longer, or if public-market volatility keeps sponsors on the sidelines, BX can still report solid near-term fee-related earnings, but the multiple may stall because investors will demand evidence that AUM is growing from real deployment rather than mark-to-market optimism. The thesis is falsified if forward fee-related earnings guidance stops accelerating, inflows normalize materially below recent pace, or management signals that deployment is slowing faster than fee base expansion.

Key Decisions for Investors

• Long BX on a 6-12 month horizon as a compounding alternative-asset manager; use pullbacks toward post-earnings support to build, with the thesis broken if next-quarter fee-related earnings growth decelerates materially.
• Pair trade: long BX / short a more credit-cycle-sensitive alternative manager basket (e.g., ARES/CG) for 1-3 months to express preference for diversified fee durability over higher-beta fundraising exposure.
• If you want convexity, buy a 6-12 month BX call spread rather than outright equity; the upside case is multiple expansion on sustained fee growth, while downside is mostly valuation compression if inflows fade.
• Set a watch item for BX fundraising and deployment metrics over the next two quarters; if AI-infrastructure commitments fail to convert into recurring fee base, reduce exposure rather than average down.